Categories AlphaGraphs, Health Care

Key highlights from Pfizer (PFE) Q3 2021 earnings results

Pfizer Inc. (NYSE: PFE) reported third quarter 2021 earnings results today.

Revenues more than doubled year-over-year to $24 billion.

Reported net income was $8.1 billion, or $1.42 per share, compared to $1.4 billion, or $0.26 per share, in the year-ago period. Adjusted net income more than doubled YoY to $7.6 billion, or $1.34 per share.

Both revenue and earnings beat expectations.

The company raised its guidance for the full year of 2021 and now expects revenue to range between $81-82 billion and adjusted EPS to range between $4.13-4.18. This compares to the previous outlook for revenue of $78-80 billion and adjusted EPS of $3.95-4.05.

Prior performance

Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!

Most Popular

HP Inc. (HPQ) stock research summary | Q3 2021

HP Inc has shown a strong performance in Q4 2021. In spite of remote working, HP has shown a strong demand for PC and printer. The company has beat Zacks

VMware Inc. (VMW) stock research summary | Q3 2021

In this era of digital transformation, the technology industry is seeing a rapid influx of innovative products and solutions that help businesses adapt to the fast-changing and complex environment. VMware

IPO Alert: Cancer drug company Nuvectis Pharma set for $30-million IPO

After months of hectic activity, the IPO market experienced a lull in the Thanksgiving week, but it is still headed for a record year though the rush led by the

Add Comment
Viewing Highlight